Derasin, Juanita P.
HRN: 13-06-62 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/08/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
01/08/2025
01/15/2025
IV
300mg
Every 8hours
Skin Infection
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes